Trastuzumab,Tucatinib
Seagen,Roche
[]
just out for #gi23
via gives accelerated approval of tucatinib in combo w/trastuzumab for previously treated ras wt her2- metastatic #colorectalcancer 1 st fda approved tx in her2 metastatic #crc 
Clinical Oncologist from Texas🇺🇸Director of @OncoAlert 🚨 Proudly NIH, NCI & MDA trained. An ounce of prevention equals a pound of cure. Views are own🌏